ArticleReproductive medicine and biology2022

A novel orally active gonadotropin-releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology.

Michiko Hamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.